Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing

Journal of Immunology

Volumn 181, Issue 8, 2008, Pages 5598-5605

  Sutherland, Rachel E ^a   Olsen, Joanna S ^a   McKinstry, Andrew ^a   Villalta, S Armando ^a   Wolters, Paul J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL SURVIVAL; BACTERIUM CONTAMINATION; CLEARANCE; CONTROLLED STUDY; INFLAMMATORY CELL; INOCULATION; INTRACELLULAR BACTERIUM; INTRACELLULAR KILLING; KLEBSIELLA PNEUMONIAE; LUNG; MAST CELL; MEDIATOR; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; WILD TYPE; ANIMAL; BACTERIAL PNEUMONIA; DISEASE MODEL; ENTEROBACTER INFECTION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; MICROBIOLOGY; MOUSE MUTANT;

ANIMALS; DISEASE MODELS, ANIMAL; IMMUNITY, NATURAL; INTERLEUKIN-6; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG; MAST CELLS; MICE; MICE, KNOCKOUT; NEUTROPHILS; PERITONEUM; PNEUMONIA, BACTERIAL; SEPSIS;

EID: 54049145874     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.8.5598     Document Type: Article

References (53)

1. Anderson, R. N., and B. L. Smith. 2005. Deaths: leading causes for 2002. Natl. Vital Stat. Rep. 53: 1-89.
2. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20: 197-216.
3. Lambrecht, B. N., J. B. Prins, and H. C. Hoogsteden. 2001. Lung dendritic cells and host immunity to infection. Eur. Respir. J. 18: 692-704. (Pubitemid 33040630)
4. Gordon, S. B., and R. C. Read. 2002. Macrophage defences against respiratory tract infections. Br. Med. Bull. 61: 45-61. (Pubitemid 34477555)
5. Moore, T. A., B. B. Moore, M. W. Newstead, and T. J. Standiford. 2000. γδ-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia. J. Immunol. 165: 2643-2650.
6. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381: 77-80. (Pubitemid 26130006)
7. Hirche, T. O., J. P. Gaut, J. W. Heinecke, and A. Belaaouaj. 2005. Myeloperoxidase plays critical roles in killing Klebsiella pneumoniae and inactivating neutrophil elastase: effects on host defense. J. Immunol. 174: 1557-1565.
8. + flux. Nature 416: 291-297.
9. Belaaouaj, A., K. S. Kim, and S. D. Shapiro. 2000. Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. Science 289: 1185-1188. (Pubitemid 30650729)
10. Belaaouaj, A., R. McCarthy, M. Baumann, Z. Gao, T. J. Ley, S. N. Abraham, and S. D. Shapiro. 1998. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat. Med. 4: 615-618. (Pubitemid 28237363)
11. Laichalk, L. L., S. L. Kunkel, R. M. Strieter, J. M. Danforth, M. B. Bailie, and T. J. Standiford. 1996. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect. Immun. 64: 5211-5218.
12. van der Poll, T., C. V. Keogh, X. Guirao, W. A. Buurman, M. Kopf, and S. F. Lowry. 1997. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J. Infect. Dis. 176: 439-444.
13. Yamamoto, N., K. Kawakami, Y. Kinjo, K. Miyagi, T. Kinjo, K. Uezu, C. Nakasone, M. Nakamatsu, and A. Saito. 2004. Essential role for the p40 subunit of interleukin-12 in neutrophil-mediated early host defense against pulmonary infection with Streptococcus pneumoniae: involvement of interferon-γ. Microbes Infect. 6: 1241-1249. (Pubitemid 39539720)
14. Lauw, F. N., J. Branger, S. Florquin, P. Speelman, S. J. van Deventer, S. Akira, and T. van der Poll. 2002. IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J. Immunol. 168: 372-378.
15. Akira, S., T. Taga, and T. Kishimoto. 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54: 1-78.
16. Dalrymple, S. A., R. Slattery, D. M. Aud, M. Krishna, L. A. Lucian, and R. Murray. 1996. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect. Immun. 64: 3231-3235.
17. van Enckevort, F. H., C. G. Sweep, P. N. Span, M. G. Netea, A. R. Hermus, and B. J. Kullberg. 2001. Reduced adrenal response and increased mortality after systemic Klebsiella pneumoniae infection in interleukin-6-deficient mice. Eur. Cytokine Network 12: 581-586.
18. Riedemann, N. C., T. A. Neff, R. F. Guo, K. D. Bernacki, I. J. Laudes, J. V. Sarma, J. D. Lambris, and P. A. Ward. 2003. Protective effects of IL-6 blockade in sepsis are linked to reduced c5a receptor expression. J. Immunol. 170: 503-507.
19. Mallen-St. Clair, J., C. T. N. Pham, S. A. Villalta, G. H. Caughey, and P. J. Wolters. 2004. Mast cell dipeptidyl peptidase I mediates survival from sepsis. J. Clin. Invest. 113: 628-634.
20. Duttlinger, R., K. Manova, G. Berrozpe, T. Y. Chu, V. DeLeon, I. Timokhina, R. S. Chaganti, A. D. Zelenetz, R. F. Bachvarova, and P. Besmer. 1995. The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice. Proc. Natl. Acad. Sci. USA 92: 3754-3758.
21. Razin, E., J. N. Ihle, D. Seldin, J. M. Mencia-Huerta, H. R. Katz, P. A. LeBlanc, A. Hein, J. P. Caulfield, K. F. Austen, and R. L. Stevens. 1984. Interleukin 3: a differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J. Immunol. 132: 1479-1486. (Pubitemid 14156069)
22. Tono, T., T. Tsujimura, U. Koshimizu, T. Kasugai, S. Adachi, K. Isozaki, S. Nishikawa, M. Morimoto, Y. Nishimune, S. Nomura, et al. 1992. c-kit Gene was not transcribed in cultured mast cells of mast cell- deficient Wsh/Wsh mice that have a normal number of erythrocytes and a normal c-kit coding region. Blood 80: 1448-1453.
23. Wolters, P. J., J. Mallen-St Clair, C. C. Lewis, S. A. Villalta, P. Baluk, D. J. Erle, and G. H. Caughey. 2005. Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient KitW-sh/KitW-sh sash mice. Clin. Exp. Allergy. 35: 82-88.
24. Echtenacher, B., D. N. Mannel, and L. Hultner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381: 75-77. (Pubitemid 26130005)
25. Nakano, T., T. Sonoda, C. Hayashi, A. Yamatodani, Y. Kanayama, T. Yamamura, H. Asai, T. Yonezawa, Y. Kitamura, and S. J. Galli. 1985. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice: evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J. Exp. Med. 162: 1025-1043. (Pubitemid 16248206)
26. Grimbaldeston, M. A., C. C. Chen, A. M. Piliponsky, M. Tsai, S. Y. Tam, and S. J. Galli. 2005. Mast cell-deficient W-sash c-kit mutant KitW-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167: 835-848.
27. Broug-Holub, E. G. B. Toews, J. F. van Iwaarden, R. M. Strieter, S. L. Kunkel, R. Paine III, and T. J. Standiford. 1997. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect. Immun. 65: 1139-1146.
28. Malaviya, R., E. A. Ross, J. I. MacGregor, T. Ikeda, J. R. Little, B. A. Jakschik, and S. N. Abraham. 1994. Mast cell phagocytosis of FimH-expressing enterobacteria. J. Immunol. 152: 1907-1914. (Pubitemid 24075724)
29. Bradding, P., Y. Okayama, P. H. Howarth, M. K. Church, and S. T. Holgate. 1995. Heterogeneity of human mast cells based on cytokine content. J. Immunol. 155: 297-307.
30. Burd, P. R., H. W. Rogers, J. R. Gordon, C. A. Martin, S. Jayaraman, S. D. Wilson, A. M. Dvorak, S. J. Galli, and M. E. Dorf. 1989. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170: 245-257.
31. Hultner, L., H. Szots, M. Welle, J. Van Snick, J. Moeller, and P. Dormer. 1989. Mouse bone marrow-derived IL-3-dependent mast cells and autonomous sublines produce IL-6. Immunology 67: 408-413. (Pubitemid 19178862)
32. Marshall, J. S., I. Leal-Berumen, L. Nielsen, M. Glibetic, and M. Jordana. 1996. Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J. Clin. Invest. 97: 1122-1128.
33. Plaut, M., J. H. Pierce, C. J. Watson, J. Hanley-Hyde, R. P. Nordan, and W. E. Paul. 1989. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores. Nature 339: 64-67. (Pubitemid 19115894)
34. Zhao, W., C. A. Oskeritzian, A. L. Pozez, and L. B. Schwartz. 2005. Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines. J. Immunol. 175: 2635-2642. (Pubitemid 41113878)
35. Bradding, P., J. A. Roberts, K. M. Britten, S. Montefort, R. Djukanovic, R. Mueller, C. H. Heusser, P. H. Howarth, and S. T. Holgate. 1994. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10: 471-480.
36. Okayama, Y., A. Semper, S. T. Holgate, and M. K. Church. 1995. Multiple cytokine mRNA expression in human mast cells stimulated via FcεRI. Int. Arch Allergy Immunol. 107: 158-159.
37. Gagari, E., M. Tsai, C. S. Lantz, L. G. Fox, and S. J. Galli. 1997. Differential release of mast cell interleukin-6 via c-kit. Blood 89: 2654-2663. (Pubitemid 27172549)
38. Diaz, B. L., H. Fujishima, Y. Kanaoka, Y. Urade, and J. P. Arm. 2002. Regulation of prostaglandin endoperoxide synthase-2 and IL-6 expression in mouse bone marrow-derived mast cells by exogenous but not endogenous prostanoids. J. Immunol. 168: 1397-1404.
39. 2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism. J. Immunol. 165: 6545-6552.
40. Supajatura, V., H. Ushio, A. Nakao, S. Akira, K. Okumura, C. Ra, and H. Ogawa. 2002. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 109: 1351-1359. (Pubitemid 34546900)
41. McCurdy, J. D., T. J. Lin, and J. S. Marshall. 2001. Toll-like receptor 4-mediated activation of murine mast cells. J. Leukocyte Biol. 70: 977-984.
42. Kruger-Krasagakes, S., A. Moller, G. Kolde, U. Lippert, M. Weber, and B. M. Henz. 1996. Production of interleukin-6 by human mast cells and basophilic cells. J. Invest. Dermatol. 106: 75-79. (Pubitemid 26052052)
43. Kandere-Grzybowska, K., R. Letourneau, D. Kempuraj, J. Donelan, S. Poplawski, W. Boucher, A. Athanassiou, and T. C. Theoharides. 2003. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J. Immunol. 171: 4830-4836. (Pubitemid 37310604)
44. Gordon, J. R., and S. J. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346: 274-276. (Pubitemid 20227406)
45. Orinska, Z., M. Maurer, F. Mirghomizadeh, E. Bulanova, M. Metz, N. Nashkevich, F. Schiemann, J. Schulmistrat, V. Budagian, J. Giron-Michel, et al. 2007. IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat. Med. 13: 927-934. (Pubitemid 47222042)
46. Sun, J., G. K. Sukhova, P. J. Wolters, M. Yang, S. Kitamoto, P. Libby, L. A. Macfarlane, J. M. Clair, and G. P. Shi. 2007. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat. Med. 13: 719-724. (Pubitemid 46889760)
47. Sun, J., G. K. Sukhova, M. Yang, P. J. Wolters, L. A. MacFarlane, P. Libby, C. Sun, Y. Zhang, J. Liu, T. L. Ennis, et al. 2007. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J. Clin. Invest. 117: 3359-3368. (Pubitemid 350096992)
48. Galli, S. J., M. Maurer, and C. S. Lantz. 1999. Mast cells as sentinels of innate immunity. Curr. Opin. Immunol. 11: 53-59.
49. Huang, C., G. T. De Sanctis, P. J. O'Brien, J. P. Mizgerd, D. S. Friend, J. M. Drazen, L. F. Brass, and R. L. Stevens. 2001. Evaluation of the substrate specificity of human mast cell tryptase β I and demonstration of its importance in bacterial infections of the lung. J. Biol. Chem. 276: 26276-26284. (Pubitemid 37412843)
50. Maurer, M., B. Echtenacher, L. Hultner, G. Kollias, D. N. Mannel, K. E. Langley, and S. J. Galli. 1998. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J. Exp. Med. 188: 2343-2348. (Pubitemid 29028506)
51. Dalrymple, S. A., L. A. Lucian, R. Slattery, T. McNeil, D. M. Aud, S. Fuchino, F. Lee, and R. Murray. 1995. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect. Immun. 63: 2262-2268.
52. Ladel, C. H., C. Blum, A. Dreher, K. Reifenberg, M. Kopf, and S. H. Kaufmann. 1997. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect. Immun. 65: 4843-4849.
53. Leon, L. R., A. A. White, and M. J. Kluger. 1998. Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice. Am. J. Physiol. 275: R269-R277. (Pubitemid 28376317)